Maria Azab

Maria Azab

Auto-generated profile, based on publicly available information

Maria Azab

University of Toronto, Faculty of Medicine, Toronto, Canada

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2023 in Journal of Dental Research
Verified
Journal Article
Open access
AMA. Miroshnychenko
A. Miroshnychenko
SIS. Ibrahim
S. Ibrahim
MAM. Azab
M. Azab
YRY. Roldan
Y. Roldan
JMJ.P.D. Martinez
J.P.D. Martinez
RBR. Brignardello-Petersen
R. Brignardello-Petersen
This study compares the effectiveness of pharmacological treatments to develop guidelines for the management of acute pain after tooth extraction. We searched Medline, EMBASE, CENTRAL, and US Clinical Trials registry on November 21, 2020. We included randomized clinical trials (RCTs) of participants undergoing dental extractions comparing 10 interventions, including acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and combinations to placebo. After duplicate screening and data abstraction, we conducted a frequentist network meta-analysis for each outcome at 6 h (i.e., pain relief, total pain relief [TOTPAR], summed pain intensity difference [SPID], global efficacy rating, rescue analgesia, and adverse effects). We assessed the risk of bias using a modified Cochrane RoB 2.0 tool and the certainty of evidence using the Grading of Recommendations, Assessment, Development, and Evaluation approach. We implemented the analyses in RStudio version 3.5.3 and classified interventions from most to least beneficial or harmful. We included 82 RCTs. Fifty-six RCTs enrolling 9,095 participants found moderate- and high-certainty evidence that ibuprofen 200 to 400 mg plus acetaminophen 500 to 1,000 mg (mean difference compared to placebo [MDp], 1.68; 95% confidence interval [CI], 1.06–2.31), acetaminophen 650 mg plus oxycodone 10 mg (MDp, 1.19; 95% CI, 0.85–1.54), ibuprofen 400 mg (MDp, 1.31; 95% CI, 1.17–1.45), and naproxen 400–440 mg (MDp, 1.44; 95% CI, 1.07–1.80) were most effective for pain relief on a 0 to 4 scale. Oxycodone 5 mg, codeine 60 mg, and tramadol 37.5 mg plus acetaminophen 325 mg were no better than placebo. The results for TOTPAR, SPID, global efficacy rating, and rescue analgesia were similar. Based on low- and very low-certainty evidence, most interventions were classified as no more harmful than placebo for most adverse effects. Based on moderate- and high-certainty evidence, NSAIDs with or without acetaminophen result in better pain-related outcomes than opioids with or without acetaminophen (except acetaminophen 650 mg plus oxycodone 10 mg) or placebo.

25 July 2023 in The Journal of the American Dental Association
Verified
Journal Article
Open access
AMAnna Miroshnychenko
Anna Miroshnychenko
MAMaria Azab
Maria Azab
SISara Ibrahim
Sara Ibrahim
YRYetiani Roldan
Yetiani Roldan
JMJuan Pablo Diaz Martinez
Juan Pablo Diaz Martinez
ACAlonso Carrasco-Labra
Alonso Carrasco-Labra
Corticosteroids are used to manage pain after surgical tooth extractions. The authors assessed the effect of corticosteroids on acute postoperative pain in patients undergoing surgical tooth extractions of mandibular third molars. The authors conducted a systematic review and meta-analysis. The authors searched the Epistemonikos database, including MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and the US clinical trials registry (ClinicalTrials.gov) from inception until April 2023. Pairs of reviewers independently screened titles and abstracts, then full texts of trials were identified as potentially eligible. After duplicate data abstraction, the authors conducted random-effects meta-analyses. Risk of bias was assessed using Version 2 of the Cochrane Risk of Bias tool and certainty of the evidence was determined using the Grading of Recommendations Assessment, Development and Evaluation approach. Forty randomized controlled trials proved eligible. The evidence suggested that corticosteroids compared with a placebo provided a trivial reduction in pain intensity measured 6 hours (mean difference, 8.79 points lower; 95% CI, 14.8 to 2.77 points lower; low certainty) and 24 hours after surgical tooth extraction (mean difference, 8.89 points lower; 95% CI, 10.71 to 7.06 points lower; very low certainty). The authors found no important difference between corticosteroids and a placebo with regard to incidence of postoperative infection (risk difference, 0%; 95% CI, -1% to 1%; low certainty) and alveolar osteitis (risk difference, 0%; 95% CI, -3% to 4%; very low certainty). Low and very low certainty evidence suggests that there is a trivial difference regarding postoperative pain intensity and adverse effects of corticosteroids administered orally, submucosally, or intramuscularly compared with a placebo in patients undergoing third-molar extractions.

25 August 2022 in The Journal of the American Dental Association
Verified
Journal Article
Closed access
MAMaria Azab
Maria Azab
SISara Ibrahim
Sara Ibrahim
ALAllan Li
Allan Li
AKAzin Khosravirad
Azin Khosravirad
ACAlonso Carrasco-Labra
Alonso Carrasco-Labra
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen

4 January 2023 in The Journal of the American Dental Association
Verified
Journal Article
Open access
AMAnna Miroshnychenko
Anna Miroshnychenko
SISara Ibrahim
Sara Ibrahim
MAMaria Azab
Maria Azab
YRYetiani Roldan
Yetiani Roldan
JMJuan Pablo Diaz Martinez
Juan Pablo Diaz Martinez
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
Local anesthesia is essential for pain control in dentistry. The authors assessed the comparative effect of local anesthetics on acute dental pain after tooth extraction and in patients with symptomatic irreversible pulpitis. The authors searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and the US Clinical Trials registry through November 21, 2020. The authors included randomized controlled trials (RCTs) comparing long- vs short-acting injectable anesthetics to reduce pain after tooth extraction (systematic review 1) and evaluated the effect of topical anesthetics in patients with symptomatic pulpitis (systematic review 2). Pairs of reviewers screened articles, abstracted data, and assessed risk of bias using a modified version of the Cochrane risk of bias 2.0 tool. The authors assessed the certainty of the evidence using the Grading of Recommendations Assessment, Development and Evaluation approach. Fourteen RCTs comparing long- vs short-acting local anesthetics suggest that bupivacaine may decrease the use of rescue analgesia and may not result in additional adverse effects (low certainty evidence). Bupivacaine probably reduces the amount of analgesic consumption compared with lidocaine with epinephrine (mean difference, -1.91 doses; 95% CI, -3.35 to -0.46; moderate certainty) and mepivacaine (mean difference, -1.58 doses; 95% CI, -2.21 to -0.95; moderate certainty). Five RCTs suggest that both benzocaine 10% and 20% may increase the number of people experiencing pain reduction compared with placebo when managing acute irreversible pulpitis (low certainty). Bupivacaine may be superior to lidocaine with epinephrine and mepivacaine with regard to time to and amount of analgesic consumption. Benzocaine may be superior to placebo in reducing pain for 20 through 30 minutes after application.

25 April 2023 in The Journal of the American Dental Association
Verified
Journal Article
Open access
AMAnna Miroshnychenko
Anna Miroshnychenko
MAMaria Azab
Maria Azab
SISara Ibrahim
Sara Ibrahim
YRYetiani Roldan
Yetiani Roldan
JMJuan Pablo Diaz Martinez
Juan Pablo Diaz Martinez
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
Background. The authors assessed the clinical effectiveness of analgesics to manage acute pain after dental extractions and pain associated with irreversible pulpitis in children. Types of Studies Reviewed. The authors searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and US Clinical Trials registry from inception through November 2020. They included randomized controlled trials comparing any pharmacologic interventions with each other and a placebo in pediatric participants undergoing dental extractions or experiencing irreversible pulpitis. After duplicate screening and data abstraction, the authors conducted random -effects meta-analyses. They assessed risk of bias using the Cochrane Risk of Bias 2.0 tool and cer-tainty of the evidence using the Grading of Recommendations Assessment, Development and Evaluation approach. Results. The authors included 6 randomized controlled trials reporting 8 comparisons. Ibuprofen may reduce pain intensity compared with acetaminophen (mean difference [MD], 0.27 points; 95% CI,-0.13 to 0.68; low certainty) and a placebo (MD,-0.19 points; 95% CI,-0.58 to 0.21; low certainty). Acetaminophen may reduce pain intensity compared with a placebo (MD,-0.13 points; 95% CI,-0.52 to 0.26; low certainty). Acetaminophen and ibuprofen combined probably reduce pain intensity compared with acetaminophen alone (MD,-0.75 points; 95% CI,-1.22 to-0.27; moderate certainty) and ibuprofen alone (MD,-0.01 points; 95% CI,-0.53 to 0.51; moderate certainty). There was very low certainty evidence regarding adverse effects. Practical Implications. Several pharmacologic interventions alone or in combination may pro-vide a beneficial effect when managing acute dental pain in children. There is a paucity of evidence regarding the use of analgesics to manage irreversible pulpitis.

9 November 2026 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
IGInna Y. Gong
Inna Y. Gong
Seyed Ali MirshahvaladSeyed Ali Mirshahvalad
Seyed Ali Mirshahvalad
EAEsraa Almutairi
Esraa Almutairi
MAMahmood Aminilari
Mahmood Aminilari
MJMeenakshi Jeeva
Meenakshi Jeeva
JKJohn Kuruvilla
John Kuruvilla